Monday, August 22, 1994
New Banexi fund to incorporate biotech
Banexi Corp., the international merchant banking arm of Banque Nationale de Paris, and
Nazem & Co., a Menlo Park, Calif., venture capital firm, announced plans to raise a
$40-60 million U.S. venture capital fund.
The Transatlantic Fund will focus on certain segments of the electronics and health care
industries, including health care